Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. - Stupp,R.; Hegi,M.E.; Mason,W.P. (Lancet Oncol, 2009)